KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Hematology / 2020 / Cilt: 37 - Sayı: 4

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge

Sudhir KUMAR
Ajay GOGIA
Ritu GUPTA
Soumya MALLICK
Soumya MALLICK
Sayfa
291–292
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

KUMAR, S., GOGIA, A., GUPTA, R., MALLICK, S., MALLICK, S. (2020). Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge. Turkish Journal of Hematology, Cilt: 37 - Sayı: 4, 291–292. https://ajindex.com/articles/412707

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Hamblin TJ. Non-hemic autoimmunity in CLL. Leuk Res 2009;33:366-367
  2. Stübgen JP. Inflammatory myopathies and lymphoma. J Neurol Sci 2016;369:377-389
  3. Kay NE. Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. Blood 1981;57:418-420
  4. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 2009;48:607-612
  5. Marie I, Guillevin L, Menard JF, Hatron PY, Cherin P, Amoura Z, Cacoub P, Bachelez H, Buzyn A, Le Roux G, Ziza JM, Brice P, Munck JN, SarrotReynauld F, Piette JC, Larroche C. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev 2012;11:615-620
  6. Levine TD. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005;52:601-607.